Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

March 31, 2020
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Series: Coronavirus Disease 2019 (CoVID-19)

[PDF-114.55 KB]

English

Details Supporting Files Related Documents You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

March 31, 2020

Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Biosafety Frequently Asked Questions.
Content Notes:

General Guidance -- Routine Diagnostic Testing -- Decentralized and Point of Care Testing -- Procedures with a High Likelihood to Generate Droplets or Aerosols -- Environmental Specimen Testing -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Specimen Packing and Shipping -- Resources.
Subjects:

[+]

Clinical Laboratory Techniques Communicable Diseases, Emerging Containment Of Biohazards Coronavirus Infections/diagnosis COVID-19 Respiratory Tract Infections/diagnosis Safety Specimen Handling
Series:

Coronavirus Disease 2019 (CoVID-19)
Document Type:

Webpage
Genre:

Guidance
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:16417c2abd325b70168ea9c88c31ad467f443b1ae97bc1a7464819a274756b24
Download URL:

https://stacks.cdc.gov/view/cdc/86282/cdc_86282_DS1.pdf
File Type:

lab-biosafety-guidelines.html

htm

More +